Skip to content
lifestyle.serversfree.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lynch Regenerative Medicine, LLC
Lynch Regenerative Medicine (LRM) Announces FDA Authorization of Two New INDs For Investigator-Initiated Clinical Trials Evaluating Injectable rhPDGF-BB for Facial Skin Quality and Treatment of Infraorbital Hollowing
November 18, 2026
FDA Authorizes Lynch Regenerative Medicine’s IND for a Phase IIb Clinical Trial for Injection of rhPDGF-BB for Treatment of Infraorbital Hollowing
October 21, 2026
Lynch Regenerative Medicine Announces Completion of Enrollment in a Phase II Clinical Trial Evaluating rhPDGF-BB in the Reconstruction of Full-Thickness Head or Neck Defects Following Skin Cancer Excision
August 18, 2026